Sponsor:
Neuroganics LLC
Code:
NCT05095844
Conditions
COVID-19
Vaccine Adverse Reaction
Vaccine Reaction
Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use
Corona Virus Infection
Eligibility Criteria
Sex: All
Age: 5 - 70+
Healthy Volunteers: Not accepted
Interventions
vaccinated
Brief summary:
Conditions
COVID-19
Vaccine Adverse Reaction
Vaccine Reaction
Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use
Corona Virus Infection
Study ID
NCT05095844
Start date
Mar 15, 2022
Status verified date
Mar, 2022
Completion date
Apr 1, 2024
Anticipated
Primary completion date
Apr 1, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 5 - 70+
Healthy Volunteers: Not accepted
Enrollment
100000 participants
Anticipated
Arms
Vaccinated
Interventions
vaccinated
Primary outcome measure
Central contacts
Locations
Neuroganics LLC
Recruiting
Northglenn, Colorado, United States, 80265
Contacts
Donald C Cooper, Ph.D.
vaccinestudy@protonmail.comPrincipal Investigator:
Donald C Cooper, Ph.D.
Sponsor
Neuroganics LLC
Last update posted
Mar 18, 2022
Last verified
Mar, 2022
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Neuroganics LLC on 2022-03-18.